# FDA recall D-0773-2016

> **Teva Pharmaceuticals USA** · Class III · drug recall initiated 2015-11-19.

## Product

NABUMETONE Tablets USP, 750 mg, 100 count bottle,Teva Pharmaceutical Industries Ltd., Jerusalem, 91010, ISRAEL

## Reason for recall

Labeling: Not Elsewhere Classified: Lack of leaflets and approved labels on bottles.

## Distribution

Nationwide and Puerto Rico.

## Key facts

- **Recall number:** D-0773-2016
- **Recalling firm:** Teva Pharmaceuticals USA
- **Classification:** Class III
- **Product type:** drug
- **Status:** Terminated
- **Initiation date:** 2015-11-19
- **Report date:** 2016-03-23
- **Termination date:** 2016-11-15

- **Voluntary/Mandated:** Voluntary: Firm initiated
- **Location:** North Wales, PA, United States

## Primary source

FDA Enforcement Reports: https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=D-0773-2016

## Citation

> AI Analytics. FDA recall D-0773-2016. Retrieved 2026-05-26 from https://api.ai-analytics.org/recall/D-0773-2016. Source: US FDA. Licensed CC0.

---

*[Dataset catalog](/datasets/) · [FDA recalls dataset](/datasets/fda-recalls) · CC0 1.0*